All Indian children aged 12
or older will become eligible for COVID-19 vaccinations from
next month, when drug maker Cadila Healthcare launches
its ZyCoV-D product, two sources with direct knowledge. | September 22, 2021
against counterfeit drugs Ahmedabad, India, May 28, 2021 Zydus Cadila, an innovation-driven pharmaceutical company announced that it has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited. The company has incorporated a new IT enabled scratch code which shall be printed under a scratchable surface. The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website. This security feature developed by Hyperlink Infosystem enables patients and institutions detect counterfeits. All that one needs to do is scratch the code and immediately verify this on an app or website, in no time.